12.04.14
Manufacturer of patient monitoring products, Masimo Corp. recently announced Food and Drug Administration (FDA) 510(k) clearance of the company’s Radius-7 wireless monitor.
The Radius-7 monitor, with Masimo's rainbow SET technology, is designed to monitor patients continuously with freedom of movement. The monitor will use Masimo Patient SafetyNet remote monitoring system to alert physicians of dire changes in the patient’s oxygen saturation and pulse rate.
The Radius-7 monitor is touted as lightweight, and is reported to reduce the need for nursing support as the monitor does not require disconnection and reconnection of cables. The wireless communication functionality of the Radius-7 monitor is designed for uninterrupted monitoring of patients even if they are not in bed.
According to the Masimo, it is believed that a patient takes more time to recover if he/she is immobile and is restricted to the bed. Thus, the Radius-7 monitor, in allowing complete mobility of patients without disruptions in monitoring, will certainly help in their speedy recovery.
Apart from the Radius-7 wearable wireless Rainbow Pulse Co-Oximeter and respiration monitor, the company continues to introduce new products like O3 regional oximetry, iSpO2 Mobile health pulse oximeter for Android, transflectance adhesive forehead pulse oximetry sensor, DCI-mini SpHb for infants and small children SpHb monitoring.
However, Zacks Equity Research analysts said monitoring products market remains quite competitive with a lot of companies vying for substantial market share. Masimo faces stiff competition from the likes of Covidien, which will soon be under the powerful roof of Medtronic, Natus Medical and CAS Medical Systems.
Notably, Covidien’s Nellcor portable SpO2 patient monitoring system, which also allows patient mobility, can give strong competition to Masimo’s Radius-7 promises, said Zacks analysts. It thus remains to be seen whether Masimo can adequately counter competition for Radius-7 and enable it to garner a sizeable market share in the near future.
Masimo is an Irvine, California-based manufacturer of noninvasive patient monitoring technologies.
The Radius-7 monitor, with Masimo's rainbow SET technology, is designed to monitor patients continuously with freedom of movement. The monitor will use Masimo Patient SafetyNet remote monitoring system to alert physicians of dire changes in the patient’s oxygen saturation and pulse rate.
The Radius-7 monitor is touted as lightweight, and is reported to reduce the need for nursing support as the monitor does not require disconnection and reconnection of cables. The wireless communication functionality of the Radius-7 monitor is designed for uninterrupted monitoring of patients even if they are not in bed.
According to the Masimo, it is believed that a patient takes more time to recover if he/she is immobile and is restricted to the bed. Thus, the Radius-7 monitor, in allowing complete mobility of patients without disruptions in monitoring, will certainly help in their speedy recovery.
Apart from the Radius-7 wearable wireless Rainbow Pulse Co-Oximeter and respiration monitor, the company continues to introduce new products like O3 regional oximetry, iSpO2 Mobile health pulse oximeter for Android, transflectance adhesive forehead pulse oximetry sensor, DCI-mini SpHb for infants and small children SpHb monitoring.
However, Zacks Equity Research analysts said monitoring products market remains quite competitive with a lot of companies vying for substantial market share. Masimo faces stiff competition from the likes of Covidien, which will soon be under the powerful roof of Medtronic, Natus Medical and CAS Medical Systems.
Notably, Covidien’s Nellcor portable SpO2 patient monitoring system, which also allows patient mobility, can give strong competition to Masimo’s Radius-7 promises, said Zacks analysts. It thus remains to be seen whether Masimo can adequately counter competition for Radius-7 and enable it to garner a sizeable market share in the near future.
Masimo is an Irvine, California-based manufacturer of noninvasive patient monitoring technologies.